REVVITY, INC. Logo

REVVITY, INC.

Provides life sciences & diagnostics technologies to support workflows from discovery to cure.

RVTY | US

Overview

Corporate Details

ISIN(s):
US7140461093
LEI:
Country:
United States of America
Address:
77 4TH AVENUE, 2451 WALTHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Revvity, Inc. is a global health science solutions company that provides technologies, expertise, and services to support workflows from discovery to cure. The company's operations are centered on Life Sciences and Diagnostics, serving customers in the pharmaceutical, biotechnology, academic, and clinical diagnostics markets. Its portfolio includes a wide range of reagents, consumables, assays, instruments, and software solutions. Key areas of focus include immunodiagnostics, reproductive health, translational multi-omics, biomarker identification, and imaging. Revvity also offers contract research services for preclinical drug discovery and clinical genetic testing. The company was formed from the life sciences and diagnostics businesses of PerkinElmer, continuing its mission to improve human health through scientific innovation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 13:39
Major Shareholding Notification
English 10.5 KB
2025-11-14 11:27
Major Shareholding Notification
English 8.7 KB
2025-11-04 22:08
Quarterly Report
10-Q
English 2.2 MB
2025-10-31 21:05
Director's Dealing
4
English 7.4 KB
2025-10-27 11:45
Regulatory News Service
8-K
English 148.5 KB
2025-10-24 22:05
Regulatory News Service
8-K
English 63.9 KB
2025-09-17 22:05
Director's Dealing
4
English 7.0 KB
2025-09-17 22:05
Director's Dealing
4
English 6.9 KB
2025-08-28 22:05
Director's Dealing
4
English 7.6 KB
2025-08-18 23:10
Director's Dealing
4
English 7.4 KB
2025-08-18 22:51
Director's Dealing
4
English 7.0 KB
2025-08-18 22:05
Director's Dealing
4
English 7.0 KB
2025-08-14 22:58
Major Shareholding Notification
English 8.6 KB
2025-08-14 19:07
Major Shareholding Notification
English 8.5 KB
2025-08-14 16:45
Major Shareholding Notification
English 10.4 KB

Automate Your Workflow. Get a real-time feed of all REVVITY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REVVITY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for REVVITY, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.